Severe insomnia and perceptual disturbances in borderline personality disorder: Diagnostic challenges in the context of polypharmacy
DOI:
https://doi.org/10.5281/zenodo.23189563Keywords:
Borderline Personality Disorder, Generalized Anxiety Disorder, Drug-Related Side Effects and Adverse Reactions, Sleep Initiation and Maintenance DisordersAbstract
Introduction: Borderline Personality Disorder (BPD) is characterized by affective instability, impulsivity, disturbed self-image, and unstable interpersonal relationships, with high psychiatric comorbidity. Generalized Anxiety Disorder (GAD) commonly coexists with BPD and is associated with greater emotional dysregulation and suicidal ideation. In severe cases, GAD may present with atypical features such as profound insomnia and dissociative symptoms, complicating the differential diagnosis with mood and psychotic disorders. Case Report: Case of a 39-year-old woman with severe BPD, GAD, Alcohol Use Disorder in remission, and a history of complex trauma receiving multiple psychotropic medications. She presented to the Emergency Department with progressive insomnia for three months, progressing to near-total sleep deprivation for two weeks, accompanied by severe anxiety, emotional lability, pressured speech, hyporexia, visual hallucinations with preserved insight, dissociative symptoms, and a recent suicide attempt. On admission, she was alert and oriented, without elevated mood or delusions. The initial differential diagnosis included hypomania and medication-induced symptoms. During hospitalization, psychotropic treatment was optimized, including discontinuation of several medications and adjustment of antipsychotic therapy. Severe insomnia initially persisted in the absence of other affective symptoms, leading to exclusion of hypomania. Sleep subsequently normalized, and the perceptual disturbances were interpreted as manifestations of severe anxiety and BPD-related decompensation rather than a primary mood or psychotic disorder. This case highlights the diagnostic challenges of severe BPD and underscores the contribution of profound insomnia and polypharmacy to perceptual disturbances and emotional dysregulation.
Downloads
References
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5-TR. 5th ed, text rev. Washington (DC): American Psychiatric Association Publishing; 2022.
2. Leichsenring F, Heim N, Leweke F, Spitzer C, Steinert C, Kernberg OF. Borderline personality disorder: a review. JAMA. 2023;329(8):670-679. Disponible en: http://doi.org/10.1001/jama.2023.0589
3. Shah AQ, Prasad D, Caropreso L, Frey BN, de Azevedo Cardoso T. The comorbidity between borderline personality disorder (BPD) and generalized anxiety disorder (GAD): a systematic review and meta-analysis. J Psychiatr Res. 2023;164:304-314. Disponible en: https://doi.org/10.1016/j.jpsychires.2023.06.009
4. Vanek J, Prasko J, Ociskova M, Hodny F, Holubova M, Minarikova K, et al. Insomnia in patients with borderline personality disorder. Nat Sci Sleep. 2021;13:239-250. Disponible en: https://doi.org/10.2147/NSS.S295030
5. Gkintoni E, Suárez Ortiz P. Neuropsychology of generalized anxiety disorder in clinical setting: a systematic evaluation. Healthcare (Basel). 2023;11(17):2446. Disponible en: https://doi.org/10.3390/healthcare11172446
6. Palagini L, Miniati M, Caruso V, Alfi G, Geoffroy PA, Domschke K, et al. Insomnia, anxiety and related disorders: a systematic review on clinical and therapeutic perspective with potential mechanisms underlying their complex link. Neurosci Appl. 2024;3:103936. Disponible en: http://doi.org/10.1016/j.nsa.2024.103936
7. Fitzpatrick S, Crenshaw A, Earle EA, Radosavljevic D, Kuo JR. The influence of sleep on emotion dysregulation in borderline personality disorder, generalized anxiety disorder, and healthy controls. Psychiatry Res. 2023;326:115273. Disponible en: http://doi.org/10.1016/j.psychres.2023.115273
8. Socci V, Festucci F, Barlattani T, Salfi F, D'Aurizio G, Rossi R, et al. Sleep quality and emotional reactivity in patients with borderline personality disorder. Front Sleep. 2024;3:1394979. Disponible en: https://doi.org/10.3389/frsle.2024.1394979
9. Mendoza Alvarez M, Verbraecken J, Claes L, Vandekerckhove M, De Picker L. Clinical predictors of insomnia in borderline personality disorder: a polysomnographic and subjective examination. Borderline Personal Disord Emot Dysregul. 2025;12(1):11. Disponible en: https://doi.org/10.1186/s40479-024-00277-w
10. Belohradova Minarikova K, Prasko J, Holubova M, Vanek J, Kantor K, Slepecky M, et al. Hallucinations and other psychotic symptoms in patients with borderline personality disorder. Neuropsychiatr Dis Treat. 2022;18:787-799.
11. Leichsenring F, Fonagy P, Heim N, Kernberg OF, Leweke F, Luyten P, et al. Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies. World Psychiatry. 2024;23(1):4-25. Disponible en: https://doi.org/10.1002/wps.21156
12. Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, Kongerslev MT, Völlm BA, Mattivi JT, et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2022;11(11):CD012956.
13. Yuan Y, Lee H, Eack SM, Newhill CE. A systematic review of the association between early childhood trauma and borderline personality disorder. J Pers Disord. 2023;37(1):16-35. Disponible en: https://doi.org/10.1521/pedi.2023.37.1.16
14. Díaz Burgos RC, Robles Calderón JA. Polifarmacia en el adulto mayor. Revisión bibliográfica. Ciencia Latina Rev Cient Multidiscip. 2024;8(4):12820-12836. Disponible en: https://doi.org/10.37811/cl_rcm.v8i4.13553
15. Hoel RW, Giddings Connolly RM, Takahashi PY. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(1):242-256. Disponible en: https://doi.org/10.1016/j.mayocp.2020.06.012
16. Fajreldines AV, Barberis E, Beldarraín MB, Valerio MA, Rodríguez V, Pellizzari M. Polimedicación, prescripción inapropiada y eventos adversos a fármacos en ancianos hospitalizados: un problema de seguridad del paciente. Rev Colomb Cienc Quim Farm. 2021;50(2):522-532. Disponible en: http://dx.doi.org/10.15446/rcciquifa.v50n2.92951
17. Papanna B, Lazzari C, Kulkarni K, Perumal S, Nusair A. Pregabalin abuse and dependence during insomnia and protocol for short-term withdrawal management with diazepam: examples from case reports. Sleep Sci. 2021;14(2):193-197. Disponible en: http://doi.org/10.5935/1984-0063.20200129
18. Fernández-Guerrero MJ. Trastorno por estrés postraumático complejo y trastorno límite de la personalidad: el debate continúa. Propuesta de diagnóstico diferencial. Pap Psicol. 2023;44(3):172-179.
19. Schulze A, Hughes N, Lis S, Krause-Utz A. Dissociative experiences and borderline personality traits. J Trauma Dissociation. 2024;25(4):436-455.
20. Schalkwijk F, Van Someren EJW, Nicolai NJ, Uijttewaal JL, Wassing R. From childhood trauma to hyperarousal in adults: the mediating effect of maladaptive shame coping and insomnia. Front Hum Neurosci. 2023;17:990581. Disponible en: https://doi.org/10.3389/fnhum.2023.990581
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ivana Pacheco Brunet, Ailin Villagrán Saez, Catalina Correa García, Nicolás Carrasco Figari, Maria Javiera Domazos Medina (Autor/a)

This work is licensed under a Creative Commons Attribution 4.0 International License.









